Cargando…
Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure
Congestive heart failure (HF) is a leading cause of morbidity and mortality worldwide. Although advances in medical therapy, mechanical support and heart transplantation have been made, almost half of all patients with HF succumb to the disease within five years of the initial diagnosis. Therefore,...
Autores principales: | Fang, Zhihua, Yin, Xiaoguang, Wang, Jianzhong, Tian, Na, Ao, Qiang, Gu, Yongquan, Liu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103788/ https://www.ncbi.nlm.nih.gov/pubmed/27882158 http://dx.doi.org/10.3892/etm.2016.3748 |
Ejemplares similares
-
Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report
por: Zhang, Chunyu, et al.
Publicado: (2017) -
Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up
por: Wang, Xiaohua, et al.
Publicado: (2017) -
Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study
por: Chen, Chun, et al.
Publicado: (2016) -
Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis
por: Fan, Mengkang, et al.
Publicado: (2019) -
Correction to: Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis
por: Fan, Mengkang, et al.
Publicado: (2019)